Antiretroviral vaginal gel shows promise against HIV.
Baleta
Adele
A
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D005260:Female; D005782:Gels; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D006679:HIV Seropositivity / Q000188:drug therapy*; D006801:Humans; D015994:Incidence; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D055118:Medication Adherence; D063065:Organophosphonates / Q000008:administration & dosage*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D013019:South Africa / Q000453:epidemiology; D000068698:Tenofovir; D014621:Vagina
D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D005782:Gels; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine